BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 01/07/2016

FDA Releases Revised Draft Guidance for Generic Paliperidone Palmitate

The FDA has made a revised draft guidance for industry available, outlining specific recommendations for bioequivalence studies to support generic applications for paliperidone palmitate extended-release injectable suspension.

Source: Federal Register — Food and Drug AdministrationOpen original release →